Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002207344 | SCV002369130 | likely benign | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256903 | SCV002531549 | likely benign | Xeroderma pigmentosum | 2021-01-31 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002443137 | SCV002683144 | likely benign | Inborn genetic diseases | 2022-02-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV002207344 | SCV004139745 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | ERCC2: BP4, BP7 |
Prevention |
RCV004543741 | SCV004762090 | likely benign | ERCC2-related disorder | 2019-10-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |